NCT04692844View on ClinicalTrials.gov

Pathophysiology of Tremor-modulating Mechanisms of Propranolol and Primidone in Essential Tremor

CompletedOBSERVATIONAL
Enrollment

61

Participants

Timeline

Start Date

August 28, 2017

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Essential Tremor
Interventions
DRUG

Propranolol

Patients will receive Propranolol in the course of their routine treatment. Results will be used to explore biological phenomena or disease processes.

DRUG

Primidone

Patients will receive Primidone in the course of their routine treatment. Results will be used to explore biological phenomena or disease processes.

Trial Locations (1)

1000

Departmet of Neurology, University Medical Centre Ljubljana, Ljubljana

All Listed Sponsors
lead

University Medical Centre Ljubljana

OTHER

NCT04692844 - Pathophysiology of Tremor-modulating Mechanisms of Propranolol and Primidone in Essential Tremor | Biotech Hunter | Biotech Hunter